Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Active, not recruiting
NCT02744092
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
811
Enrollment(s)
151
Study location(s)
Interventional (Not Applicable)
Cancer
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Blood Clot
Completed
NCT03247569
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)
300
Enrollment(s)
6
Study location(s)
Observational
Atrial Fibrillation
Completed
NCT03581409
Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm
198
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Aneurysm, Cerebral
Endovascular Procedures
Completed
NCT02734433
Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors
12
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Advanced Solid Tumors
Completed
NCT03182829
In Vitro Diagnostic Test for DOAC in Urine
880
Enrollment(s)
18
Study location(s)
Observational
Anticoagulant Therapy
Completed
NCT05326360
Ramosetron on Late PONV (Postoperative Nausea and Vomiting)
144
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Postoperative Nausea and Vomiting
Breast Cancer Female
Recruiting
NCT04662515
NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications
300
Enrollment(s)
2
Study location(s)
Observational
Surgery, Oral
Hemorrhage
Postoperative Complications
Oral Surgical Procedures
Anticoagulants Causing Adverse Effects in Therapeutic Use
Anticoagulant-induced Bleeding
Completed
NCT03366428
Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer
51
Enrollment(s)
7
Study location(s)
Interventional (Phase I)
Malignant Neoplasm of Breast
51
52
53
54
55